Libbs Farmacêutica LTDA   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (1958)

Organization Overview

First Clinical Trial
2014
NCT04332978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Libbs Farmacêutica LTDA

Active Ingredients

Drugs in Phase 4 Trials (1)

mometasone (elocon) (1 trial)

Drugs in Phase 3 Trials (1)

fluticasone (cutivate) (1 trial)

Drugs in Phase 2 Trials (1)

methotrexate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Eczema (Phase 4)

Graft vs Host Disease (Phase 2)

Hematologic Neoplasms (Phase 2)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3